Latest News & Updates

Breaking News

  • 2 hours ago

  • Pharma Now Editorial Team

Intravacc Secures French CIR Approval as Recognized Private Research Organization for 2025–2027
Breaking News
ImmuPharma Initiates IND-Enabling Program for Kapiglucagon via FDA 505(b)(2) Pathway

Pharma Now Editorial Team

Other trending news you may like to read

Intravacc Secures French CIR Approval as Recognized Private Research Organization for 2025–2027

Intravacc gains French CIR recognition for 2025–2027, letting French pharma partners declare outsourced vaccine R&D expenses under the tax credit framework.

Pharma Now Editorial Team

Pharma Now

ImmuPharma Initiates IND-Enabling Program for Kapiglucagon via FDA 505(b)(2) Pathway

ImmuPharma initiates IND-enabling activities for Kapiglucagon, pursuing a 505(b)(2) pathway with a pre-IND FDA meeting in preparation.

Pharma Now Editorial Team

Pharma Now

Zealand Pharma Presents Phase 2 ZUPREME-1 Petrelintide Data at ADA 2026 Scientific Sessions

Zealand Pharma presents Phase 2 ZUPREME-1 petrelintide data at ADA 2026, with implications for peptide manufacturing capacity in the amylin analog class.

Pharma Now Editorial Team

Pharma Now

Total Nutrition Inc. Recalls Moringa Capsules Across Four Retail Channels After FDA Salmonella Alert

Total Nutrition Inc. recalls moringa capsules across four lots after FDA and CDC flag potential Salmonella contamination in an ongoing investigation.

Pharma Now Editorial Team

Pharma Now